日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of regorafenib in patients with advanced pretreated melanoma: results of the RegoMel phase II clinical trial

瑞戈非尼治疗既往接受过治疗的晚期黑色素瘤患者的疗效和安全性:RegoMel II期临床试验结果

Dirven, I; Bertels, C; Moreels, Y; Kessels, J I; Vanlaer, N; Vander Mijnsbrugge, A-S; Vounckx, M; Dirks, I; Raes, L; Geeraerts, X; Stevens, L; von Kemp, B; Fasolino, G; Awada, G; Janssen, T; Caljon, B; Lefevre, T; Everaert, H; Rogiers, A; Vandemeulebroucke, J; Tuyaerts, S; Neyns, B

Sonmat, a citizen-science enabled Kimjang kimchi case study on associations between hand and kimchi microbiota

Sonmat,一项由公民科学支持的泡菜案例研究,探讨了手部和泡菜微生物群之间的关联。

Van Beeck, Wannes; Eilers, Tom; Smets, Wenke; Delanghe, Lize; Vandenheuvel, Dieter; Tuyaerts, Ines; Van Malderen, Joke; Ahannach, Sarah; Michiels, Katrien; Dricot, Caroline; Van de Vliet, Nele; Huys, Ae Jin; De Boever, Patrick; Lebeer, Sarah

Age-related canine reproductive health: impact on fertility and disorders

犬类年龄相关的生殖健康:对生育能力和疾病的影响

Duerinck, Johnny; Lescrauwaet, Louise; Dirven, Iris; Del'haye, Jacomi; Stevens, Latoya; Geeraerts, Xenia; Vaeyens, Freya; Geens, Wietse; Brock, Stefanie; Vanbinst, Anne-Marie; Everaert, Hendrik; Caljon, Ben; Bruneau, Michaël; Lebrun, Laetitia; Salmon, Isabelle; Kockx, Marc; Tuyaerts, Sandra; Neyns, Bart; Hanim, Maulida Selma; Chotimanukul, Sroisuda

Oncolytic HSV-1 expressing FLT3L kills melanoma, glioblastoma, and pancreatic cancer cells in vitro and induces immunogenic cell death

表达FLT3L的溶瘤性HSV-1在体外可杀死黑色素瘤、胶质母细胞瘤和胰腺癌细胞,并诱导免疫原性细胞死亡

Tuyaerts, Sandra; Geeraerts, Xenia; Reale, Alberto; Stevens, Latoya; Bertazzon, Giada; Brons, Jack; Janssen, Toon; Van Riet, Ivan; Calistri, Arianna; Neyns, Bart

Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity

针对胶质母细胞瘤的抗原敏感型B7-H3靶向纳米抗体CAR-T细胞的临床前评估提示,可能存在靶向肿瘤外毒性。

Meeus, Fien; Funeh, Cyprine Neba; Awad, Robin Maximilian; Zeven, Katty; Autaers, Dorien; De Becker, Ann; Van Riet, Ivan; Goyvaerts, Cleo; Tuyaerts, Sandra; Neyns, Bart; Devoogdt, Nick; De Vlaeminck, Yannick; Breckpot, Karine

Intratumoral administration of the immunologic adjuvant AS01(B) in combination with autologous CD1c (BDCA-1)(+)/CD141 (BDCA-3)(+) myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma

在难治性晚期黑色素瘤患者中,瘤内注射免疫佐剂AS01(B)联合自体CD1c(BDCA-1)(+)/CD141(BDCA-3)(+)髓系树突状细胞,并加用伊匹木单抗和静脉注射纳武利尤单抗。

Tijtgat, Jens; Geeraerts, Xenia; Boisson, Anais; Stevens, Latoya; Vounckx, Manon; Dirven, Iris; Schwarze, Julia Katharina; Raeymaeckers, Steven; Forsyth, Ramses; Van Riet, Ivan; Tuyaerts, Sandra; Willard-Gallo, Karen; Neyns, Bart

PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD-1 blockade

PI3K/mTOR抑制诱导肿瘤微环境重塑,并使pS6高表达的子宫平滑肌肉瘤对PD-1阻断剂敏感

Wout De Wispelaere ,Daniela Annibali ,Sandra Tuyaerts ,Julie Messiaen ,Asier Antoranz ,Gautam Shankar ,Nikolina Dubroja ,Alejandro Herreros-Pomares ,Regina E M Baiden-Amissah ,Marie-Pauline Orban ,Marcello Delfini ,Emanuele Berardi ,Thomas Van Brussel ,Rogier Schepers ,Gino Philips ,Bram Boeckx ,Maria Francesca Baietti ,Luigi Congedo ,Kiave Yune HoWangYin ,Emilie Bayon ,Anne-Sophie Van Rompuy ,Eleonora Leucci ,Sebastien P Tabruyn ,Francesca Bosisio ,Massimiliano Mazzone ,Diether Lambrechts ,Frédéric Amant

A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)(+)/CD141 (BDCA-3)(+) myeloid dendritic cells in solid tumors

一项随机 II 期临床试验,研究立体定向放射治疗 (SBRT) 联合全身性帕博利珠单抗,或不联合瘤内注射阿维鲁单抗/伊匹木单抗,以及 CD1c (BDCA-1)(+)/CD141 (BDCA-3)(+) 髓系树突状细胞治疗实体瘤的疗效。

Vounckx, Manon; Tijtgat, Jens; Stevens, Latoya; Dirven, Iris; Ilsen, Bart; Vandenbroucke, Frederik; Raeymaeckers, Steven; Vekens, Karolien; Forsyth, Ramses; Geeraerts, Xenia; Van Riet, Ivan; Schwarze, Julia Katharina; Tuyaerts, Sandra; Decoster, Lore; De Ridder, Mark; Dufait, Ines; Neyns, Bart

Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

更正:帕博利珠单抗、放射疗法和免疫调节五药鸡尾酒疗法治疗既往接受过治疗的持续性、复发性或转移性宫颈癌或子宫内膜癌患者:II期PRIMMO研究结果

De Jaeghere, Emiel A; Tuyaerts, Sandra; Van Nufel, An M T; Belmans, Ann; Bogaerts, Kris; Baiden-Amissah, Regina; Lippens, Lien; Vuylsteke, Peter; Henry, Stéphanie; Trinh, Xuan Bich; van Dam, Peter A; Aspeslagh, Sandrine; De Caluwé, Alex; Naert, Eline; Lambrechts, Diether; Hendrix, An; De Wever, Olivier; Van de Vijver, Koen K; Amant, Frédéric; Vandecasteele, Katrien; Denys, Hannelore G

Multifactorial inhibition of Candida albicans by combinations of lactobacilli and probiotic Saccharomyces cerevisiae CNCM I-3856.

乳酸杆菌和益生菌酿酒酵母 CNCM I-3856 的组合对白色念珠菌的多因素抑制作用

Spacova Irina, Allonsius Camille Nina, De Boeck Ilke, Oerlemans Eline, Tuyaerts Ines, Van de Vliet Nele, van den Broek Marianne F L, Jimenez Luciana, Boyer Mickaël, Rodriguez Bertrand, Ballet Nathalie, Lebeer Sarah